Press releases

DZHK Launches Open Call for Translational Research Funding

The German Centre for Cardiovascular Research (DZHK) has published an open call for the funding of innovative translational research projects.

Read more

Funding for three Collaborative Research Centres at DZHK sites

The German Research Foundation (DFG) is establishing new Collaborative Research Centres and extending existing research networks. Several DZHK sites…

Read more

Higher levels of nitric oxide do not automatically mean better vascular function

Red blood cells have a greater influence on the function of blood vessels than previously thought. Researchers at the DZHK’s RheinMain site have shown…

Read more

Genetic heart failure: a new target for cause-based therapy

A study conducted by the Heidelberg/Mannheim site of the German Centre for Cardiovascular Research (DZHK) has identified the overactivity of CaMKIIδ…

Read more

European cutting-edge research: two ICRPA projects with DZHK participation

Scientists from the United Kingdom, France, Germany, and the Netherlands are pooling their expertise to develop new approaches for the early…

Read more

Treatment of spontaneous coronary artery dissection (SCAD-ALIGN-DZHK31 Trial)

A consortium of ten international academic organisations within the Global Cardiovascular Research Funders Forum (GCRFF) is launching a new…

Read more

New Leadership Team for the German Centre for Cardiovascular Research

The German Centre for Cardiovascular Research has elected a new Executive Board – Prof. Heribert Schunkert will serve as the new spokesperson. The new…

Read more

Could weight-loss drugs also help prevent cardiovascular disease in the context of primary prevention?

Researchers at the German Centre for Cardiovascular Research (DZHK) from its North and Rhine-Main sites have, for the first time, modelled the…

Read more

Laureates of the 92th DGK Annual Meeting

The 92nd Annual Meeting of the German Cardiac Society – Cardiovascular Research (DGK) was held in Mannheim from 8 to 11 April 2026. During the…

Read more

DZHK Study: Spironolactone Shows No Significant Benefit in Heart Failure with Preserved Ejection Fraction (SPIRIT-HF-DZHK8 Trial)

Results of the DZHK trial SPIRIT-HF-DZHK8, presented at ACC.26, show no clear evidence of efficacy – interpretability limited due to COVID-related…

Read more